BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5904165)

  • 1. Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings.
    Kopin IJ
    Pharmacol Rev; 1966 Mar; 18(1):513-23. PubMed ID: 5904165
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influencing of catecholamine liberation in nerve endings].
    Schönhöfer P
    Schweiz Rundsch Med Prax; 1971 Jun; 60(26):867-70. PubMed ID: 5092314
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine.
    Vanhoutte PM; Lorenz RR; Tyce GM
    J Pharmacol Exp Ther; 1973 May; 185(2):386-94. PubMed ID: 4703828
    [No Abstract]   [Full Text] [Related]  

  • 4. gamma-Aminobutyric acid reduces the evoked release of [3H]-noradrenaline from sympathetic nerve terminals [proceedings].
    Bowery NG; Hudson AL
    Br J Pharmacol; 1979 May; 66(1):108P. PubMed ID: 454903
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

  • 6. Some factors affecting catecholamine uptake, storage, and release in adrenergic nerve granules.
    Von Euler US
    Circ Res; 1967 Dec; 21(6):Suppl 3:5-11. PubMed ID: 4866852
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sympathetic nervous system and catecholamines in hypertension].
    Jäättelä A
    Duodecim; 1974; 90(9):676-84. PubMed ID: 4608898
    [No Abstract]   [Full Text] [Related]  

  • 8. Life cycle of vesicles in sympathetic nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971 Oct; 218 Suppl():67P-68P. PubMed ID: 5130641
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular aspects of the storage and uptake of catecholamines.
    Kirshner N; Schanberg SM; Ferris RM
    Adv Drug Res; 1971; 6():121-56. PubMed ID: 4334740
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of 6-hydroxydopamine.
    Thoenen H; Tranzer JP
    Annu Rev Pharmacol; 1973; 13():169-80. PubMed ID: 4576887
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. 3. Selective increase of norepinephrine in the rat pineal gland consecutive to depletion of neuronal 5-hydroxytryptamine.
    Jaim-Etcheverry G; Zeiher LM
    J Pharmacol Exp Ther; 1971 Jul; 178(1):42-8. PubMed ID: 4253294
    [No Abstract]   [Full Text] [Related]  

  • 12. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves.
    Axelrod J; Kopin IJ
    Prog Brain Res; 1969; 31():21-32. PubMed ID: 4900113
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines.
    Moura D; Azevedo I; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):153-9. PubMed ID: 2234100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 15. The noradrenaline content of the varicosities of sympathetic adrenergic nerve terminals in the rat.
    Dahlström A; Häggendal J; Hökfelt T
    Acta Physiol Scand; 1966; 67(3):289-94. PubMed ID: 6007784
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions.
    Tranzer JP; Thoenen H; Snipes RL; Richards JG
    Prog Brain Res; 1969; 31():33-46. PubMed ID: 4900115
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase in health and disease.
    Udupa A; Srinivasan S; Udupa KN
    Indian J Physiol Pharmacol; 1974; 18(2):73-85. PubMed ID: 4414711
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Intraneuronal distributions and metabolic pathways of the adrenergic neurotransmitter.
    Stéfano FJ
    Acta Physiol Lat Am; 1973; 23(6):626-8. PubMed ID: 4369053
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in the vesicular noradrenaline of nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971; 217 Suppl():27P-28P. PubMed ID: 5571930
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of N-dimethyldiphenoxyethylamine on the resorption of norepinephrine by sympathetic nerve endings].
    Vagne A; Nedergaard OA; Brunet MA; Boucherle A
    C R Seances Soc Biol Fil; 1970; 164(8):1769-71. PubMed ID: 4325790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.